Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
22/06/2026 07:13
BUZZ-Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up ** Shares of Insilico Medicine Cayman TopCo 3696.HK jump 8.5% to HK$41.58, their highest point since June 1
** On track for a third straight session of gain
** AI developer in pharmaceuticals enters into research and development collaboration with SK Biopharmaceuticals 326030.KS to discover AI-enabled innovative drug candidates in neuroimmune area of central nervous system
** Says it will be eligible to receive up to $18 mln in upfront and near-term milestone payments and total potential deal value exceeds $2.5 bln, including development, regulatory, and commercial milestone payments
** YTD, stock up 9.3%, while the Hang Seng Biotech Index .HSBIO down 16.6%
(Reporting by Donny Kwok)
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker